Pcn312 - How Has the Relaunched Cancer Drugs Fund Affected Nice’s Approval of Novel Oncology Technologies?
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.394
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV